Highnoon Laboratories Limited (PSX: HINOON)
Pakistan
· Delayed Price · Currency is PKR
884.23
-12.65 (-1.41%)
At close: Feb 4, 2025
Highnoon Laboratories Revenue
Highnoon Laboratories had revenue of 6.29B PKR in the quarter ending September 30, 2024, with 21.97% growth. This brings the company's revenue in the last twelve months to 23.02B, up 22.13% year-over-year. In the year 2023, Highnoon Laboratories had annual revenue of 19.77B with 24.98% growth.
Revenue (ttm)
23.02B
Revenue Growth
+22.13%
P/S Ratio
2.03
Revenue / Employee
10.03M
Employees
2,295
Market Cap
46.85B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 19.77B | 3.95B | 24.98% |
Dec 31, 2022 | 15.82B | 2.82B | 21.65% |
Dec 31, 2021 | 13.00B | 2.30B | 21.53% |
Dec 31, 2020 | 10.70B | 1.65B | 18.24% |
Dec 31, 2019 | 9.05B | 1.54B | 20.59% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
GlaxoSmithKline Pakistan | 56.23B |
Abbott Laboratories (Pakistan) | 63.81B |
The Searle Company | 28.32B |
Shifa International Hospitals | 24.67B |
Citi Pharma | 12.93B |
Ferozsons Laboratories | 15.96B |
Otsuka Pakistan | 3.18B |